Cellectis Biologics
Biotechnology Company
Why pick this one
Cellectis develops pioneering off-the-shelf CAR T-cell therapies and has 25 years of expertise in gene editing.
Best for
- oncology treatments requiring innovative gene-editing solutions
- patients seeking allogeneic cancer therapies
Look elsewhere if
- customized treatment options for individual patients
- non-oncology therapeutic areas
Specialties
- allogeneic CAR T-cell therapies
- gene editing using TALEN® technology
Certifications
- listed on Nasdaq
- listed on Euronext Growth
What makes them different
- 25 years of experience in gene editing technology
- pioneered off-the-shelf CAR T-cell therapies
- develops immunotherapy products aimed at addressing unmet medical needs
- strong intellectual property with over 300 granted patents
- partners with industry leaders such as Allogene and Servier
- Years in business
- 25
- Serves
- Paris, New York, Raleigh
Distilled from this business's own website.
Contact & Location
- Address
- 2500 Sumner Blvd, Raleigh, NC 27616
- Phone
- 9844779025
- Website
- http://www.cellectis.com/en/about
Services
- clinical-stage biopharmaceutical development
- immunotherapy product candidates